Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
Option Care Health Management
Management Kriterienprüfungen 2/4
Option Care Health's CEO ist John Rademacher, ernannt in Aug 2017, hat eine Amtszeit von 6.75 Jahren. Die jährliche Gesamtvergütung beträgt $16.61M, bestehend aus 6% Gehalt und 94% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.09% der Aktien des Unternehmens, im Wert von $4.54M. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.3 Jahre bzw. 5.3 Jahre.
Wichtige Informationen
John Rademacher
Geschäftsführender
US$16.6m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 6.0% |
| Amtszeit als Geschäftsführer | 6.8yrs |
| Eigentum des Geschäftsführers | 0.09% |
| Durchschnittliche Amtszeit des Managements | 2.4yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 5.4yrs |
Jüngste Management Updates
Recent updates
Option Care Health: A Deep Dive Into Its Market Dominance
May 31Option Care Health, Inc.'s (NASDAQ:OPCH) Shareholders Might Be Looking For Exit
May 23
We Ran A Stock Scan For Earnings Growth And Option Care Health (NASDAQ:OPCH) Passed With Ease
May 10Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Apr 11Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 42% Discount?
Mar 28Is It Time To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Feb 12Option Care Health (NASDAQ:OPCH) Has A Pretty Healthy Balance Sheet
Jan 02There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Dec 19Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 27% Undervaluation?
Dec 06With EPS Growth And More, Option Care Health (NASDAQ:OPCH) Makes An Interesting Case
Nov 08Is It Too Late To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Oct 26Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Sep 13Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 24% Discount?
Aug 30Does Option Care Health (NASDAQ:OPCH) Deserve A Spot On Your Watchlist?
Aug 10Is Option Care Health, Inc. (NASDAQ:OPCH) Potentially Undervalued?
Jul 27Here's Why Option Care Health (NASDAQ:OPCH) Can Manage Its Debt Responsibly
Jun 09An Intrinsic Calculation For Option Care Health, Inc. (NASDAQ:OPCH) Suggests It's 37% Undervalued
May 25What Is Option Care Health, Inc.'s (NASDAQ:OPCH) Share Price Doing?
Apr 24Here's Why We Think Option Care Health (NASDAQ:OPCH) Might Deserve Your Attention Today
Apr 11We Like These Underlying Return On Capital Trends At Option Care Health (NASDAQ:OPCH)
Mar 17Option Care Health (NASDAQ:OPCH) Seems To Use Debt Quite Sensibly
Mar 05Estimating The Intrinsic Value Of Option Care Health, Inc. (NASDAQ:OPCH)
Feb 21Should You Think About Buying Option Care Health, Inc. (NASDAQ:OPCH) Now?
Jan 16Should You Be Adding Option Care Health (NASDAQ:OPCH) To Your Watchlist Today?
Jan 04Some Shareholders Feeling Restless Over Option Care Health, Inc.'s (NASDAQ:OPCH) P/E Ratio
Dec 05We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Nov 22The Return Trends At Option Care Health (NASDAQ:OPCH) Look Promising
Nov 10Option Care Health, Inc.'s (NASDAQ:OPCH) Intrinsic Value Is Potentially 41% Above Its Share Price
Sep 30Is Now The Time To Put Option Care Health (NASDAQ:OPCH) On Your Watchlist?
Sep 12Option Care Health announces secondary offering of 11M shares of common stock
Aug 16Option Care Health: Trigger Heavy On This Long-Term Cash Compounder
Aug 10At US$34.49, Is Option Care Health, Inc. (NASDAQ:OPCH) Worth Looking At Closely?
Aug 07Option Care Health Q2 2022 Earnings Preview
Jul 26Are Investors Undervaluing Option Care Health, Inc. (NASDAQ:OPCH) By 35%?
Jun 30We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Jun 18Is Now The Time To Put Option Care Health (NASDAQ:OPCH) On Your Watchlist?
Jun 06Option Care Health (NASDAQ:OPCH) Is Doing The Right Things To Multiply Its Share Price
May 25Option Care Health: Top Infusion Therapy Player With Promising Growth Prospects
May 04Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$273m |
| Dec 31 2023 | US$17m | US$1m | US$267m |
| Sep 30 2023 | n/a | n/a | US$257m |
| Jun 30 2023 | n/a | n/a | US$240m |
| Mar 31 2023 | n/a | n/a | US$159m |
| Dec 31 2022 | US$7m | US$954k | US$151m |
| Sep 30 2022 | n/a | n/a | US$178m |
| Jun 30 2022 | n/a | n/a | US$175m |
| Mar 31 2022 | n/a | n/a | US$173m |
| Dec 31 2021 | US$8m | US$669k | US$140m |
| Sep 30 2021 | n/a | n/a | US$82m |
| Jun 30 2021 | n/a | n/a | US$48m |
| Mar 31 2021 | n/a | n/a | US$9m |
| Dec 31 2020 | US$1m | US$500k | -US$8m |
| Sep 30 2020 | n/a | n/a | -US$42m |
| Jun 30 2020 | n/a | n/a | -US$86m |
| Mar 31 2020 | n/a | n/a | -US$92m |
| Dec 31 2019 | US$856k | US$487k | -US$76m |
Vergütung im Vergleich zum Markt: JohnDie Gesamtvergütung ($USD16.61M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD8.49M).
Entschädigung vs. Einkommen: JohnDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.
Geschäftsführer
John Rademacher (57 yo)
6.8yrs
Amtszeit
US$16,613,200
Vergütung
Mr. John C. Rademacher is the President of Option Care Health, Inc. (formerly known as Option Care Enterprises Inc.) and has serves as a Director since 2019. Mr. Rademacher is the Chief Executive Officer o...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, President & Director | 6.8yrs | US$16.61m | 0.090% $ 4.6m | |
| Executive VP & CFO | 8.8yrs | US$8.32m | 0.033% $ 1.7m | |
| Chief Operating Officer | 1.4yrs | US$3.52m | 0.025% $ 1.3m | |
| General Counsel & Corporate Secretary | 2.2yrs | US$2.55m | 0.010% $ 528.4k | |
| Chief Human Resources & Diversity Officer | 2.4yrs | US$2.08m | 0% $ 0 | |
| Chief Information Officer | no data | keine Daten | keine Daten | |
| Senior VP & Chief Compliance Officer | 2.4yrs | keine Daten | keine Daten | |
| Senior Vice President of Operations | no data | keine Daten | keine Daten | |
| Senior Vice President of Quality & Clinical Services | 2.4yrs | keine Daten | keine Daten | |
| Chief Growth Officer | 2yrs | keine Daten | 0.0036% $ 186.8k | |
| Chief Medical Officer | no data | keine Daten | keine Daten | |
| Senior VP & Chief Information Security Officer | less than a year | keine Daten | keine Daten |
2.4yrs
Durchschnittliche Betriebszugehörigkeit
46yo
Durchschnittliches Alter
Erfahrenes Management: OPCHDas Führungsteam des Unternehmens gilt als erfahren (2.3 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, President & Director | 5.4yrs | US$16.61m | 0.090% $ 4.6m | |
| Independent Director | 5.4yrs | US$245.00k | 0.039% $ 2.0m | |
| Independent Director | 5.4yrs | US$245.00k | 0.041% $ 2.1m | |
| Director | less than a year | keine Daten | keine Daten | |
| Independent Non Executive Chairman of the Board | 5.4yrs | US$571.55k | 0.16% $ 8.4m | |
| Independent Director | 9.4yrs | US$237.50k | 0.062% $ 3.2m | |
| Independent Director | 5.4yrs | US$255.00k | 0.041% $ 2.1m | |
| Independent Director | 9.4yrs | US$257.00k | 0.060% $ 3.1m | |
| Independent Director | 2.1yrs | US$248.50k | 0.0027% $ 140.4k | |
| Independent Director | less than a year | keine Daten | 0.0041% $ 209.5k | |
| Independent Director | less than a year | keine Daten | 0.0010% $ 51.6k | |
| Independent Director | 2.1yrs | US$250.00k | 0.0010% $ 51.6k |
5.4yrs
Durchschnittliche Betriebszugehörigkeit
62yo
Durchschnittliches Alter
Erfahrener Vorstand: OPCHDie Vorstandsmitglieder gelten als erfahren (5.3 Jahre durchschnittliche Amtszeit).